Probiotic industry specialists are hoping that the FTC’s recent dispute with Dannon (White Plains, NY) over probiotic label claims will not devalue the sound science that exists within the field of probiotic science.
Probiotic industry specialists are hoping that the FTC’s recent dispute with Dannon (White Plains, NY) over probiotic label claims will not devalue the sound science that exists within the field of probiotic science.
Dannon agreed to pull claims from its Activia yogurt and DanActive dairy drink earlier this month after the FTC took issue with claims relating to the ability to relieve digestive “irregularity” (Activia) and the prevention of cold and flu (DanActive).
Michael Shahani, director of operations for Nebraska Cultures, had this to say about the state of probiotic science and modern nutrition:
“With Dannon’s recent $21 million settlement for Activia with the FTC, I think that it’s important to stress that there are real and important benefits from probiotics. My father, Dr. Khem Shahani, who was a pioneer in the field of probiotics and is widely regarded as one of the world’s leading authorities on probiotics and their role in digestive health, did research showing that probiotics have the potential to alleviate a number of digestive aliments. Yogurt is not the best method to ingest probiotics because you’d need to eat an efficacious dose of yogurt to benefit from them-and many yogurts are high in fat and sugars. Supplements made with freeze-dried probiotics are a much more efficient and cost-effective method to gain the numerous benefits of probiotics.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.